Ezetimibe and Hyzaar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Hyzaar (hydrochlorothiazide; losartan potassium). Common drug interactions include white blood cell count increased among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Hyzaar. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.
What is Ezetimibe?
Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.
What is Hyzaar?
Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 16,614 Hyzaar users. Check the latest studies of Hyzaar.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
50 people who take Ezetimibe and Hyzaar together, and have interactions are studied.

What are the common drug interactions of Ezetimibe and Hyzaar, by gender? *:
female:
- White blood cell count increased
- Abdominal discomfort
- Alopecia (absence of hair from areas of the body)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Aphasia (damage to the parts of the brain that control language)
- Asthma
- Blood sodium increased
- Breast cyst
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Decreased appetite
male:
- Chronic kidney disease
- Ingrowing nail
- Anaemia (lack of blood)
- Cardiac enzymes increased
- Cardiac pacemaker replacement
- Dehydration (dryness resulting from the removal of water)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Hypersensitivity
What are the common drug interactions of Ezetimibe and Hyzaar, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Fatigue (feeling of tiredness)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Cardiac pacemaker replacement
- Hypersensitivity
- Multiple allergies (allergy to multiple agents)
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Renal tubular necrosis (death of kidney tubules)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Asthma
- Coronary arterial stent insertion
60+:
- Nausea (feeling of having an urge to vomit)
- Arthralgia (joint pain)
- Abasia (inability to walk)
- Altered state of consciousness (altered state of mind)
- Anaemia (lack of blood)
- Anxiety
- Asthenia (weakness)
- Blood bilirubin decreased
- Blood chloride decreased
- Blood urea increased
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 8 people, 16.00%
- Joint Pain: 7 people, 14.00%
- Stress And Anxiety: 6 people, 12.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.00%
- Pain: 5 people, 10.00%
- Diabetes: 5 people, 10.00%
- Muscle Spasms (muscle contraction): 4 people, 8.00%
- Asthma: 4 people, 8.00%
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 6.00%
- Chest Pain: 3 people, 6.00%
* Approximation only. Some reports may have incomplete information.
Do you take Ezetimibe and Hyzaar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ezetimibe and Hyzaar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ezetimibe:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Hyzaar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ezetimibe and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hyzaar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ezetimibe and hydrochlorothiazide; losartan potassium (the active ingredients of Ezetimibe and Hyzaar, respectively), and Ezetimibe and Hyzaar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Gilenya cause Haemorrhoids? - 2 seconds ago
- Could Amlodipine Besylate cause Polyneuropathy? - 6 seconds ago
- Could Bactrim Ds cause Hyperglycemia? - 7 seconds ago
- Drug interactions of Ativan and Amoxicillin - 13 seconds ago
- Could Intron A cause Systemic Lupus Erythematosus? - 13 seconds ago
- Could Perindopril Erbumine cause Atrioventricular Block Complete? - 15 seconds ago
- Could Lamotrigine cause Mycoplasma Infection? - 17 seconds ago
- Could Insulin cause Pulmonary Artery Stenosis Congenital? - 18 seconds ago
- Drug interactions of Midol and Gabapentin - 29 seconds ago
- Could Mirapex cause Acute Kidney Failure? - 29 seconds ago